Search Results - Vidnovic, Nick

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers

    The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers by Leong, Chee-Onn, Vidnovic, Nick, DeYoung, Maurice Phillip, Sgroi, Dennis, Ellisen, Leif W

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Evaluation of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in Patients with Non-Hodgkin's Lymphoma (NHL) Having Previously Received Autologous Stem Cell Transplant (ASCT)

    Evaluation of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in Patients with Non-Hodgkin's Lymphoma (NHL) Having Previously Received Autologous Stem Cell Transplant (ASCT) by Jacobs, Samuel A., McCook, Barry, Torok, Frank, Avril, Norbert, Vidnovic, Nick, Joyce, Judy, Molina, Arturo

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Cellular Localization Pattern of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in a Patient with Low-Grade Non-Hodgkin's Lymphoma (NHL)

    Cellular Localization Pattern of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in a Patient with Low-Grade Non-Hodgkin's Lymphoma (NHL) by Jacobs, Samuel A., Harrison, Anthony M., Swerdlow, Steven H., Foon, Kenneth A., Avril, Norbert, Vidnovic, Nick, McCarty, Kenneth S., Saville, Wayne

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: